BIO MEDICA LABORATORIES L (BMLL-SM) Share Price Rises 11.46% Today
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
BIO MEDICA LABORATORIES L Share Price rose to Rs 162, up Rs 16.65 or 11.46% from the previous close of Rs 145.35. The stock opened at Rs 153, touched Rs 163.8, slipped to Rs 152.65, and reported turnover of Rs 0.26 crore. Market capitalisation stood at Rs 182.78 crore.
The data confirms a strong one-day move, but it does not identify a company-specific trigger. So the most reliable way to read this session is through verified price action, valuation and profitability metrics. Within Healthcare and the Pharmaceuticals & Drugs industry, the stock stands out because its P/E of 15.66 is below the same-industry median of 31.29, while ROE of 99.59 and ROCE of 64.18 are far above benchmark levels.
BIO MEDICA LABORATORIES L Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 162 |
| Previous Close | Rs 145.35 |
| Today's Move | Rs 16.65 (+11.46%) |
| Open | Rs 153 |
| High | Rs 163.8 |
| Low | Rs 152.65 |
| Turnover | Rs 0.26 crore |
| Market Capitalisation | Rs 182.78 crore |
| Market Cap Category | Micro Cap |
BIO MEDICA LABORATORIES L (BMLL-SM) rose to Rs 162 from the previous close of Rs 145.35, a move of Rs 16.65 or 11.46%. The stock opened at Rs 153, reached a high of Rs 163.8, recorded a low of Rs 152.65.
BIO MEDICA LABORATORIES L Share Price moved sharply higher in the latest session. Against the previous close of Rs 145.35, the stock gained Rs 16.65 to Rs 162. It opened at Rs 153, then traded in an intraday range of Rs 152.65 to Rs 163.8.
The open was already above the previous close, and the stock spent the session holding a firm range before ending near the day’s high. Turnover was Rs 0.26 crore. Based on the supplied data, this qualifies as a notable same-day gain, but the move should not be treated as proof of a confirmed underlying catalyst because none is provided in the dataset.
BIO MEDICA LABORATORIES L (BMLL-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 182.78 crore |
| P/E Ratio | 15.66x |
| P/B Ratio | 10.08x |
| ROE | 99.59% |
| ROCE | 64.18% |
| EPS | Rs 9.28 |
| Book Value Per Share | Rs 14.42 |
| Dividend Yield | 0% |
BIO MEDICA LABORATORIES L (BMLL-SM) fundamental metrics show P/E 15.66x, P/B 10.08x, ROE 99.59%, ROCE 64.18%. These figures provide context only and are not a buy or sell signal.
BIO MEDICA LABORATORIES L has a market capitalisation of Rs 182.78 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 15.66x, P/B at 10.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 99.59% and ROCE of 64.18%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 9.28, book value per share of Rs 14.42, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 15.66x |
| Benchmark Median P/E | 31.29x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 10.08x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 99.59% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 64.18% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 182.78 crore |
| Benchmark Median Market Cap | Rs 720.34 crore |
BIO MEDICA LABORATORIES L (BMLL-SM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
BIO MEDICA LABORATORIES L (BMLL-SM) has a P/E ratio of 15.66x, which is below the benchmark median of 31.29x, a difference of -49.95%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
BIO MEDICA LABORATORIES L (BMLL-SM) has a ROE of 99.59%, which is above the benchmark median of 11.79%, a difference of +744.7%. BIO MEDICA LABORATORIES L (BMLL-SM) has a ROCE of 64.18%, which is above the benchmark median of 13.63%, a difference of +370.87%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,69,309.92 | 38.29 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,425.7 | 83.18 | 13.77 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,347.12 | 86.48 | 21.02 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,919.92 | 25.73 | 4.31 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,392.76 | 33.99 | 3.26 | 11.83 | 16 |
BIO MEDICA LABORATORIES L (BMLL-SM) has a P/E ratio of 15.66x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 99.59% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 64.18% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. BIO MEDICA LABORATORIES L (BMLL-SM) has a market capitalisation of Rs 182.78 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching BIO MEDICA LABORATORIES L
- The stock rose 11.46% today to Rs 162 from Rs 145.35.
- Intraday trading stayed within Rs 152.65 to Rs 163.8 after opening at Rs 153.
- P/E of 15.66 is below the same-industry median of 31.29 and average of 48.12.
- ROE of 99.59 and ROCE of 64.18 are far above industry medians of 11.79 and 13.63.
- At Rs 182.78 crore market cap, it is much smaller than the major pharma peers shown.
About BIO MEDICA LABORATORIES L
BIO MEDICA LABORATORIES L is classified under Healthcare and Pharmaceuticals & Drugs. Based on the supplied data, the key verified context is its position as a relatively small listed company in a large industry universe, with reported return ratios that screen well above many benchmark figures.
Track BIO MEDICA LABORATORIES L Share Price on Univest
Use BIO MEDICA LABORATORIES L (BMLL-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Use the BIO MEDICA LABORATORIES L (BMLL-SM) live share-price page, the Univest top gainers screener and Univest market blogs to follow price moves, valuation ratios, profitability metrics, sector comparisons and related market coverage.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is BIO MEDICA LABORATORIES L Share Price rising today?
Ans. The stock rose 11.46% to Rs 162 from Rs 145.35, a gain of Rs 16.65. The supplied data confirms the move but does not provide a company-specific reason. The previous close was Rs 145.35.
What is the latest BIO MEDICA LABORATORIES L Share Price Today?
Ans. The latest reported price is Rs 162. The stock opened at Rs 153, hit a high of Rs 163.8 and a low of Rs 152.65. The previous close was Rs 145.35.
How does BIO MEDICA LABORATORIES L compare on valuation?
Ans. Its P/E is 15.66, below the same-industry median of 31.29, while its P/B is 10.08, above the industry median of 2.88. This means earnings valuation and book-value valuation are pointing in different directions.
How strong are the company’s profitability ratios?
Ans. ROE is 99.59 and ROCE is 64.18. Both are much higher than the same-industry medians of 11.79 and 13.63, and also above all 5 displayed major peers in the article.
